Up to $19.3 million in federal funding to support pilot-scale rare earth element separation development. STILLWATER, Okla., May 21, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. ( ...
(NASDAQ: REGN) today announced positive results from the Phase 1/2 LINKER-AL2 trial evaluating Lynozyfic® (linvoseltamab) in adults with second-line-plus systemic amyloid light chain (AL) amyloidosis, ...
A few days ago, the SEC proposed major changes to the registered public offering process in an effort to dramatically increase the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results